ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 50 filers reported holding ALBIREO PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,898,000 | +78.6% | 63,616 | +39.4% | 0.00% | 0.0% |
| Q4 2021 | $1,063,000 | -49.1% | 45,647 | -31.8% | 0.00% | 0.0% |
| Q3 2021 | $2,089,000 | -1.3% | 66,968 | +11.3% | 0.00% | 0.0% |
| Q2 2021 | $2,116,000 | +19.4% | 60,156 | +19.6% | 0.00% | 0.0% |
| Q1 2021 | $1,772,000 | +35.4% | 50,277 | +44.0% | 0.00% | 0.0% |
| Q4 2020 | $1,309,000 | -11.5% | 34,909 | -21.2% | 0.00% | 0.0% |
| Q3 2020 | $1,479,000 | +81.9% | 44,317 | +44.4% | 0.00% | 0.0% |
| Q2 2020 | $813,000 | +80.7% | 30,691 | +11.6% | 0.00% | – |
| Q1 2020 | $450,000 | -37.8% | 27,508 | -3.4% | 0.00% | -100.0% |
| Q4 2019 | $724,000 | +83.8% | 28,464 | +44.5% | 0.00% | – |
| Q3 2019 | $394,000 | -40.9% | 19,693 | -4.8% | 0.00% | -100.0% |
| Q2 2019 | $667,000 | -10.7% | 20,688 | -10.8% | 0.00% | 0.0% |
| Q1 2019 | $747,000 | +25.8% | 23,193 | -4.2% | 0.00% | 0.0% |
| Q4 2018 | $594,000 | -40.8% | 24,216 | -20.4% | 0.00% | 0.0% |
| Q3 2018 | $1,003,000 | +35.5% | 30,439 | +46.1% | 0.00% | 0.0% |
| Q2 2018 | $740,000 | +38.8% | 20,840 | +27.4% | 0.00% | 0.0% |
| Q1 2018 | $533,000 | – | 16,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 198,800 | $5,266,000 | 2.26% |
| Perceptive Advisors | 1,960,139 | $51,924,000 | 0.84% |
| Chicago Capital, LLC | 502,212 | $13,304,000 | 0.77% |
| Birchview Capital, LP | 48,000 | $1,272,000 | 0.77% |
| Artal Group S.A. | 500,360 | $13,255,000 | 0.37% |
| HEARTLAND ADVISORS INC | 150,000 | $3,974,000 | 0.35% |
| Eversept Partners, LP | 78,029 | $2,066,988 | 0.28% |
| ArrowMark Colorado Holdings LLC | 956,990 | $25,351,000 | 0.26% |
| PA Capital LLC | 12,987 | $344,000 | 0.25% |
| Ikarian Capital, LLC | 100,500 | $2,662,000 | 0.21% |